[1]
|
Heywood, J.T., Fonarow, G.C., Costanzo, M.R., Mathur, V.S., Wigneswaran, J.R. and Wynne, J. (2007) High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized with Acute Decompensated Heart Failure: A Report from the ADHERE Database. Journal of Cardiac Failure, 13, 422-430.
https://doi.org/10.1016/j.cardfail.2007.03.011
|
[2]
|
Hebert, K., Dias, A., Delgado, M.C., Franco, E., Tamariz, L., Steen, D., Trahan, P., Major, B. and Arcement, L.M. (2010) Epidemiology and Survival of the Five Stages of Chronic Kidney Disease in a Systolic Heart Failure Population. European Journal of Heart Failure, 12, 861-865. https://doi.org/10.1093/eurjhf/hfq077
|
[3]
|
Roger, V.L. (2013) Epidemiology of Heart Failure. Circulation Research, 113, 646-659. https://doi.org/10.1161/CIRCRESAHA.113.300268
|
[4]
|
Fonarow, G.C., Stough, W.G., Abraham, W.T., et al. (2007) Characteristics, Treatments, and Outcomes of Patients with Preserved Systolic Function Hospitalized for Heart Failure. A Report from the OPTIMIZE-HF Registry. Journal of the American College of Cardiology, 50, 768-777. https://doi.org/10.1016/j.jacc.2007.04.064
|
[5]
|
Bhatia, R.S., Tu, J.V., Lee, D.S., et al. (2006) Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study. New England Journal of Medicine, 355, 260-269. https://doi.org/10.1056/NEJMoa051530
|
[6]
|
McDonald, K. (2008) Diastolic Heart Failure in the Elderly: Underlying Mechanisms and Clinical Relevance. International Journal of Cardiology, 125, 197-202.
https://doi.org/10.1016/j.ijcard.2007.10.002
|
[7]
|
McCullough, P.A., Khandelwal, A.K., McKinnon, J.E., et al. (2005) Outcomes and Prognostic Factors of Systolic as Compared with Diastolic Heart Failure in Urban America. Congestive Heart Failure, 11, 6-11.
https://doi.org/10.1111/j.1527-5299.2005.03731.x
|
[8]
|
Tehrani, F., Phan, A., Chien, C.V., Morrissey, R.P., Rafique, A.M. and Schwarz, E. R. (2009) Value of Medical Therapy in Patients > 80 Years of Age with Heart Failure and Preserved Ejection Fraction. American Journal of Cardiology, 103, 829-833.
https://doi.org/10.1016/j.amjcard.2008.11.047
|
[9]
|
Damman, K., Valente, M.A., Voors, A.A., O’Connor, C.M., van Veldhuisen, D.J. and Hillege, H.L. (2014) Renal Impairment, Worsening Renal Function, and Outcome in Patients with Heart Failure: An Updated Meta-Analysis. European Heart Journal, 35, 455-469. https://doi.org/10.1093/eurheartj/eht386
|
[10]
|
Voors, A.A., Gori, M., Liu, L.C., Claggett, B., Zile, M.R., Pieske, B., et al. (2015) PARAMOUNT Investigators. Renal Effects of the Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Patients with Heart Failure and Preserved Ejection Fraction. European Journal of Heart Failure, 17, 510-517. https://doi.org/10.1002/ejhf.232
|
[11]
|
Damman, K., Voors, A.A., Navis, G., van Veldhuisen, D.J. and Hillege, H.L. (2011) The Cardiorenal Syndrome in Heart Failure. Progress in Cardiovascular Diseases, 54, 144-153. https://doi.org/10.1016/j.pcad.2011.01.003
|
[12]
|
Dini, F.L., Demmer, R.T., Simioniuc, A., Morrone, D., Donati, F., Guarini, G., et al. (2012) Right Ventricular Dysfunction Is Associated with Chronic Kidney Disease and Predicts Survival in Patients with Chronic Systolic Heart Failure. European Journal of Heart Failure, 14, 287-294. https://doi.org/10.1093/eurjhf/hfr176
|
[13]
|
Navaneethan, S.D., Wehbe, E., Heresi, G.A., Gaur, V., Minai, O.A., Arrigain, S., et al. (2014) Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension. Clinical Journal of the American Society of Nephrology, 9, 855-863.
https://doi.org/10.2215/CJN.10191013
|
[14]
|
Reinglas, J., et al. (2010) Cardiorenal Syndrome and Heart Failure. Current Opinion in Cardiology, 25, 141-147. https://doi.org/10.1097/HCO.0b013e328335fed7
|
[15]
|
Miller, A.B. and Piña, I.L. (2009) Understanding Heart Failure with Preserved Ejection Fraction: Clinical Importance and Future Outlook. Congestive Heart Failure, 15, 186-192. https://doi.org/10.1111/j.1751-7133.2009.00063.x
|
[16]
|
Iwanaga, Y. and Miyazaki, S. (2010) Heart Failure, Chronic Kidney Disease, and Biomarkers—An Integrated Viewpoint. Circulation Journal, 74, 1274-1282.
https://doi.org/10.1253/circj.CJ-10-0444
|
[17]
|
McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Bohm, M., Burri, H., Butler, J., Celutkiene, J., Chioncel, O., et al. (2021) 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic. European Heart Journal, 42, 4901. https://doi.org/10.1093/eurheartj/ehab670
|
[18]
|
Shah, S.J., Katz, D.H., Selvaraj, S., et al. (2015) Phenomapping for Novel Classification of Heart Failure with Preserved Ejection Fraction. Circulation, 131, 269-279.
https://doi.org/10.1161/CIRCULATIONAHA.114.010637
|
[19]
|
Carnes, J. and Gordon, G. (2020) Biomarkers in Heart Failure with Preserved Ejection Fraction: An Update on Progress and Future Challenges. Heart, Lung and Circulation, 29, 62-68. https://doi.org/10.1016/j.hlc.2019.05.180
|
[20]
|
Lund, L.H., Donal, E., Oger, E., et al. (2014) Association between Cardiovascular vs. Non-Cardiovascular Comorbidities and Outcomes in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure, 16, 992-1001.
https://doi.org/10.1002/ejhf.137
|
[21]
|
Reinglas, J., Haddad, H., Davies, R.A. and Mielniczuk, L. (2010) Cardiorenal Syndrome and Heart Failure. Current Opinion in Cardiology, 25, 141-147.
https://doi.org/10.1097/HCO.0b013e328335fed7
|
[22]
|
Bowling, C.B., Sanders, P.W., Allman, R.M., Rogers, W.J., Patel, K., Aban, I.B., Rich, M.W., Pitt, B., White, M., Bakris, G.C., et al. (2013) Effects of Enalapril in Systolic Heart Failure Patients with and without Chronic Kidney Disease: Insights from the SOLVD Treatment Trial. International Journal of Cardiology, 167, 151-156.
https://doi.org/10.1016/j.ijcard.2011.12.056
|
[23]
|
Massie, B.M., et al. (2008) Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. The New England Journal of Medicine, 359, 2456-2467.
https://doi.org/10.1056/NEJMoa0805450
|
[24]
|
Pitt, B., et al. (2014) Spironolactone for Heart Failure with Preserved Ejection Fraction. The New England Journal of Medicine, 370, 1383-1392.
https://doi.org/10.1056/NEJMoa1313731
|
[25]
|
McMurray, J.J.V., et al. (2014) Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure. The New England Journal of Medicine, 371, 993-1004.
https://doi.org/10.1056/NEJMoa1409077
|
[26]
|
Voors, A.A., et al. (2015) Renal Effects of the Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Patients with Heart Failure and Preserved Ejection Fraction. European Journal of Heart Failure, 17, 510-517. https://doi.org/10.1002/ejhf.232
|
[27]
|
Redfield, M.M. (2017) Heart Failure with Preserved Ejection Fraction. The New England Journal of Medicine, 376, 896-897. https://doi.org/10.1056/NEJMc1615918
|
[28]
|
Lim, S.L., Gandhi, M., Woo, K.L., Chua, H.R., Lim, Y.C., Sim, D.K.L., Lee, S.S.G., Teoh, Y.L., Richards, A.M. and Lam, C.S.P. (2020) Nitrates in Combination with Hydralazine in Cardiorenal Syndrome: A Randomized Controlled Proof-of-Concept Study. ESC Heart Failure Journal, 7, 4267-4276. https://doi.org/10.1002/ehf2.13076
|
[29]
|
Lim Shir, L., Benson, L., Dahlström, U., Lam Carolyn, S.P. and Lund Lars, H. (2017) Association between Use of Long-Acting Nitrates and Outcomes in Heart Failure with Preserved Ejection Fraction. Circulation: Heart Failure, 10, e003534.
https://doi.org/10.1161/CIRCHEARTFAILURE.116.003534
|
[30]
|
Mullens, W., Damman, K., Harjola, V., Mebazaa, A., Brunner-La Rocca, H., Martens, P., et al. (2019) The Use of Diuretics in Heart Failure with Congestion—A Position Statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 21, 137-155.
https://doi.org/10.1002/ejhf.1369
|
[31]
|
Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G.F., Coats, A.J.S., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 37, 2129-2200.
https://doi.org/10.1093/eurheartj/ehw128
|
[32]
|
Núñez, J., González, M., Miñana, G., Garcia-Ramón, R., Sanchis, J., Bodí, V., et al. (2012) Continuous Ambulatory Peritoneal Dialysis as a Therapeutic Alternative in Patients with Advanced Congestive Heart Failure. European Journal of Heart Failure, 14, 540-548. https://doi.org/10.1093/eurjhf/hfs013
|
[33]
|
Leskovar, B., Furlan, T., Poznic, S., Potisek, M. and Adamlje, A. (2017) Hemodialysis Treatment of Cardiorenal Syndrome. Clinical Nephrology, 88, 57-60.
https://doi.org/10.5414/CNP88FX14
|